zintick

Zai Lab ZLAB

Zai Lab Ltd · Nasdaq · Pharmaceutical Preparations

$23.04-2.29%close on Oct. 28, 2026 · volume 704K · Yahoo Finance

Price, last 47 sessions

$24.00$26.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $27.00 · low $22.04 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 19, 2026Yajing Chen
Chief Financial Officer
Sold
10b5-1 plan
260$27.00$7,020
Aug. 12, 2026William Lis
director
Sold
10b5-1 plan
8,506$25.00$212,650
Aug. 11, 2026Yajing Chen
Chief Financial Officer
Sold
10b5-1 plan
619$25.00$15,475

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 8 →
  • 8-KOct. 23, 2026, 6:06 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedZai Lab Announces $250 Million Private Placement of 11,340,000 ADSs at $22.04 to Fund Zoci Development

  • 4Oct. 5, 2026, 4:44 p.m. ETView on SEC.gov
  • 4Aug. 21, 2026, 4:16 p.m. ETView on SEC.gov
  • 4Aug. 18, 2026, 4:16 p.m. ETView on SEC.gov
  • 4Aug. 13, 2026, 4:15 p.m. ETView on SEC.gov
  • 4Aug. 13, 2026, 4:15 p.m. ETView on SEC.gov
  • 10-QAug. 6, 2026, 6:40 a.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 6:34 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits